Compare Nucleus Soft. with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -1.13% of over the last 5 years
The company has declared Negative results for the last 3 consecutive quarters
With ROE of 14.9, it has a Expensive valuation with a 2.2 Price to Book Value
Falling Participation by Institutional Investors
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Software Products
INR 1,993 Cr (Small Cap)
15.00
20
1.68%
-0.45
14.89%
2.19
Total Returns (Price + Dividend) 
Latest dividend: 12.5 per share ex-dividend date: Jul-11-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Nucleus Software Exports Ltd: Valuation Shift Signals Price Attractiveness Change
Nucleus Software Exports Ltd has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, reflecting a recalibration in price attractiveness relative to its historical averages and peer group. Despite a modest day gain of 0.75%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a nuanced investment outlook amid a challenging market backdrop and sector dynamics.
Read full news article
Nucleus Software Exports Ltd Downgraded to Strong Sell Amid Valuation and Technical Weakness
Nucleus Software Exports Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The downgrade reflects deteriorating technical signals, stretched valuation metrics, weakening financial performance, and a challenging market outlook for this small-cap software products company.
Read full news article
Nucleus Software Exports Ltd Faces Bearish Momentum Amid Technical Downgrade
Nucleus Software Exports Ltd, a small-cap player in the Software Products sector, has experienced a notable shift in technical momentum, with key indicators signalling a bearish trend. Despite a modest recovery over the past month, the stock’s year-to-date and longer-term returns lag behind the broader market, prompting a downgrade to a Strong Sell rating by MarketsMOJO on 8 July 2026.
Read full news article Announcements 
Nucleus Software Exports Limited - Other General Purpose
14-Nov-2019 | Source : NSENucleus Software Exports Limited has informed the Exchange regarding Disclosure of Related Party transactions for the half year ended September 30, 2019 pursuant to Regulation 23(9) of SEBI ( LODR) Regulations, 2015.
Nucleus Software Exports Limited - Code of Conduct under SEBI(PIT) Reg., 2015
13-Nov-2019 | Source : NSENucleus Software Exports Limited has informed the Exchange regarding the Code of Conduct under SEBI(PIT) Reg., 2015We wish to inform you that the Board of Directors of the Company has approved a revised Code of
Nucleus Software Exports Limited - Analysts/Institutional Investor Meet/Con. Call Updates
22-Oct-2019 | Source : NSENucleus Software Exports Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates.This is to inform you that the Investor/ Analyst Earning Conference Call of the Company would be held on Thursday, the 24th Oct, 2019.
Corporate Actions 
No Upcoming Board Meetings
Nucleus Software Exports Ltd has declared 125% dividend, ex-date: 10 Jul 26
No Splits history available
Nucleus Software Exports Ltd has announced 1:1 bonus issue, ex-date: 03 Aug 07
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (1.07%)
Held by 66 FIIs (4.47%)
Karmayogi Holdings Private Limited (33.59%)
Barca Global Master Fund, Lp (1.82%)
17.56%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 2.15% vs 3.05% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 66.91% vs -21.26% in Dec 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 8.46% vs -3.51% in Sep 2024
Growth in half year ended Sep 2025 is -2.80% vs -35.55% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 7.95% vs -2.09% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -16.33% vs -29.56% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 5.26% vs 0.70% in Mar 2025
YoY Growth in year ended Mar 2026 is -28.38% vs -14.93% in Mar 2025






